Stocks and Investing Stocks and Investing
Fri, August 13, 2021
Thu, August 12, 2021
Wed, August 11, 2021
Tue, August 10, 2021

Vamil Divan Maintained (AXSM) at Strong Buy with Decreased Target to $55 on, Aug 10th, 2021


Published on 2024-10-27 17:35:51 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $118 to $55 on, Aug 10th, 2021.

Vamil has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021